Syncona Portfolio Ltd
- SEC CIK
- 0001725042
Holdings, Q2 2026
Positions as of Jun 30, 2026, filed Aug 6, 2026.SEC
- Positions
- 1
- −1 vs. Q1 2026
- Total value
- $26.63M
- +$919.45K (+3.6%) vs. Q1 2026
Compare with Q1 2026: new, added, reduced and sold out
Positions
Long positions only. Changes compare share counts with Q1 2026.
| Security | Class | Shares | Value | % of portfolio | Change in shares | Action | History |
|---|---|---|---|---|---|---|---|
| AUTLAUTOLUS THERAPEUTICS LTD | SPON ADS | 16,640,720 | $26.63M | 100.00% | 00.0% | Unchanged | View |
Sold out since Q1 2026 (1)
Positions held at the end of Q1 2026 that are no longer in this filing.
| Security | Class | Shares, Q1 2026 | Value, Q1 2026 | % of portfolio, Q1 2026 |
|---|---|---|---|---|
| IPSCCENTURY THERAPEUTICS INC | COM | 1,213,056 | $2.74M | 10.66% |
13F filings by quarter
| Quarter | Filed | Positions | Total value | Changes | Filing |
|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | 1 | $26.63M | vs. Q1 2026 | SEC |
| Q1 2026 | May 14, 2026 | 2 | $25.71M | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 5, 2026 | 2 | $34.32M | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 6, 2025 | 2 | $27.73M | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 7, 2025 | 2 | $38.62M | vs. Q1 2025 | SEC |
| Q1 2025 | May 7, 2025 | 2 | $26.37M | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 6, 2025 | 3 | $52.97M | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 14, 2024 | 3 | $80.74M | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 13, 2024 | 3 | $85.87M | vs. Q1 2024 | SEC |
| Q1 2024 | May 7, 2024 | 2 | $150.05M | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 1, 2024 | 4 | $157.75M | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 1, 2023 | 4 | $67.12M | vs. Q2 2023 | SEC |
| Q2 2023 | Jul 27, 2023 | 4 | $66.34M | vs. Q1 2023 | SEC |
| Q1 2023 | May 12, 2023 | 4 | $61.51M | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 14, 2023 | 4 | $63M | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 4, 2022 | 4 | $57.54M | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 10, 2022 | 4 | $70.38M | vs. Q1 2022 | SEC |
| Q1 2022 | May 31, 2022 | 4 | $104.68M | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 11, 2022 | 4 | $104.68M | – | SEC |